Vitiligo is a long-term skin condition characterized by the gradual loss of pigmentation, which occurs due to the absence or dysfunction of melanocytes—the cells responsible for producing melanin. This results in distinct white patches that may remain stable or expand over time. The condition can manifest at any age and may progress unpredictably, with some individuals experiencing slow and localized pigment loss, while others notice widespread depigmentation across different areas of the body. Though it primarily affects the skin, vitiligo can also lead to premature graying or whitening of hair on the scalp, eyelashes, eyebrows, and beard.
The impact of vitiligo extends beyond its physical effects, often influencing a person’s emotional and psychological well-being. Because skin pigmentation plays a significant role in appearance, individuals with vitiligo may experience self-consciousness, social anxiety, or reduced confidence, particularly when depigmented areas are highly visible. While vitiligo does not cause physical pain or discomfort, its visible nature can lead to social stigma, prompting many affected individuals to seek medical guidance and therapeutic options to manage its progression and appearance.
Cuba is a global leader in dermatological research, offering exclusive access to Melagenina Plus, a breakthrough vitiligo treatment developed at the Placental Histotherapy Centre. Patients from around the world seek vitiligo treatment in Cuba due to the high success rates, natural formulation, and non-invasive approach. Unlike conventional therapies, this clinically proven treatment stimulates melanin production without requiring sun exposure, ensuring effective and long-lasting repigmentation. With expert medical care, personalized treatment plans, and access to Cuba’s world-renowned biotechnology, patients benefit from a safe, effective, and scientifically advanced solution for vitiligo.
The exact cause of vitiligo is not fully understood, but several factors may contribute to its development, including:
Vitiligo is classified into two main categories based on how the condition affects the skin:
Vitiligo can be further categorized based on the extent and distribution of pigment loss:
The primary symptom of vitiligo is the appearance of white or depigmented patches on the skin. Other symptoms may include:
Vitiligo is not painful and does not cause physical discomfort, but the psychological impact can be significant, leading to anxiety, depression, or self-consciousness.
A dermatologist typically diagnoses vitiligo through a physical examination and medical history review. Additional tests may include:
Melagenina Plus is a clinically proven, topical vitiligo treatment, developed at the Placental Histotherapy Centre in Cuba. It utilizes human placental extract, a biologically active compound known for its regenerative properties, to stimulate melanocyte activity and enhance melanin production in depigmented skin. Unlike conventional treatments, Melagenina Plus accelerates pigment restoration, offering a non-invasive, side-effect-free solution for individuals with vitiligo. The treatment is applied directly to affected areas, and clinical studies indicate an 86% success rate, particularly in patients with early-stage vitiligo or localized depigmentation.
This innovative vitiligo therapy is well-tolerated and does not require sun exposure for activation, making it suitable for all skin types. Melagenina Plus halts vitiligo progression while promoting natural skin tone restoration. Its unique formulation stimulates melanocyte reproduction around the borders and within depigmented areas, improving skin cell regeneration for long-term results. Many patients seeking effective vitiligo treatment in Cuba choose Melagenina Plus due to its high efficacy, safety profile, and natural approach to repigmentation.
Treatment for vitiligo with Melagenina Plus is conducted through specialized medical services in Cuba. The ointment is an alcoholic extract derived from human placenta, enriched with Melagenina and calcium, which work together to reactivate melanocytes and restore pigment. When used properly, visible results can appear within 3 to 7 days, with progressive improvement over time.
Melagenina Plus is safe for all ages, including children, pregnant and nursing women, and the elderly, with no reported side effects. To receive vitiligo treatment in Cuba, a consultation with a specialist is required. After evaluating the case, the specialist will determine the length of treatment and the required dosage. Patients are advised to discontinue all skin treatments at least 45 days before arriving in Cuba to optimize results. Please note that Melagenina Plus is not available for purchase without a medical evaluation and prescription from a qualified doctor.
Our experts recommend the suspension of all skin treatments 45 days before the arrival to Cuba.Having evaluated the case, the specialist determines the length of treatment and indicates the number of bottles of the therapeutic product to be used.